Fusion Antibodies has the privilege of showcasing their expertise and sponsoring the Antibody Engineering & Therapeutics conference in San Diego this December. The Antibody Engineering & Therapeutics conference which began over 25 year ago is an exhibition of Antibody Science, Technology and Networking. The conference will feature over 225 speakers on a range of topics […]
Fusion Antibodies managing director Paul Kerr recently met with PharmaTV News’ Adrian Dawkes to dissuss our Antibody Humanziation platform. Fusion Antibodies managing director Paul Kerr recently met with PharmaTV News‘ Adrian Dawkes to dissuss our Antibody Humanziation platform. Check out the video interview above or the video transcript below. Video Transcript Adrian Dawkes: Hello and welcome to […]
Fusion Antibodies ltd has the great honour and privilege to welcome the 20th Human Antibodies & Hybridoma conference to our home city of Belfast this November. It continues to be a great time of hope and optimism in the knowledge of the immune system since the first report of the immortalisation of monoclonal antibodies by […]
Fusion Antibodies are happy to announce we have entered into a partnership with Swiss contract manufacturing organisation Celonic AG to collaborate on the development of high yield stable cell lines. The deal will allow clients of Fusion Antibodies a direct & efficient supply path to clinical trial material by taking advantage of the scale-up and […]
Fusion Antibodies are looking to hire a Business Development Manager to join their team based in Belfast, UK. Are you looking to join an innovative manufacturer of a range of high quality antibodies for drug development and diagnostics? Do you want to benefit from genuine career prospects with a clear route to progress to a […]
Fusion Antibodies are pleased to announce a second collaboration with Aerpio Therapeutics to apply our CDRx Antibody Humanization platform to Aerpio’s Mouse Monoclonal Antibody. Fusion Antibodies Ltd are excited to announce our second collaboration with Aerpio Therapeutics, of Cincinnati, Ohio. Aerpio are biopharmaceutical company focused on advancing first-in-class treatments for the eye. Following the success […]
